Summary

Overview
The global cannabigerol (CBG) gummies market reached US$ 2.47 billion in 2023 and is expected to reach US$ 44.4 billion by 2031 growing with a CAGR of 43.5% during the forecast period 2024-2031.
Cannabigerol (CBG) gummies are chewy confections that are infused with cannabigerol, a cannabinoid found in the cannabis plant that does not produce psychoactive effects. Often called the "mother of all cannabinoids," CBG serves as a foundational compound from which other cannabinoids, such as CBD (cannabidiol) and THC (tetrahydrocannabinol), are derived.
Cannabigerol (CBG) gummies are formulated to contain a specific amount of CBG extract, along with various flavorings and sweeteners, making them an appealing choice for consumers. They come in different varieties, including soft and hard candies, and can be produced using full-spectrum, broad-spectrum, or isolated forms of cannabinoids.
Market Dynamics: Drivers
Legalization of cannabis and product innovations
The demand for the global cannabigerol (CBG) gummies market is driven by multiple factors. One of the primary factors is the legalization of cannabis and product innovations. The legalization of cannabis, whether for medical or recreational purposes, has significantly expanded the market access and consumer base for products containing cannabinoids like Cannabigerol (CBG). As more states and countries move to legalize cannabis, consumers have greater access to a wider variety of cannabis-derived products, including CBG gummies. This increased accessibility encourages more people to explore these products, contributing to market growth.
Companies are continuously innovating in the CBG gummies market to meet the growing consumer demand for wellness-oriented products. People are more interested in products that utilize natural, plant-based ingredients instead of artificial additives. In response to this demand, companies are formulating CBG gummies with organic cane sugar, fruit pectin, and natural flavors and colors derived from sources like spirulina and turmeric. This shift towards clean ingredients is particularly appealing to health-conscious consumers who seek a more natural approach to experiencing the potential benefits of CBG.
Moreover, key player strategies such as partnerships and collaborations would propel this cannabigerol (CBG) gummies market growth. For instance, in June 2022, Cronos Group Inc. announced that they had reached the third productivity milestone in their collaboration to produce eight cultured cannabinoids. Utilizing Ginkgo's organism design platform, Cronos has successfully met the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid believed to mitigate the appetite-stimulating effects of THC. This access to additional rare cannabinoids will enhance Cronos' innovation pipeline and support its commercialization strategy.
Restraints
Factors such as high production costs, and regulatory challenges, are expected to hamper the market.
Segment Analysis
The global cannabigerol (CBG) gummies market is segmented based on category, flavor, form, application, and region.
The cannabigerol (CBG) segment accounted for approximately 66.4% of the global cannabigerol (CBG) gummies market share
The cannabigerol (CBG) segment is expected to hold the largest market share over the forecast period. Cannabigerol (CBG) gummies are typically made with natural ingredients, including fruit flavors, to enhance their taste and appeal to consumers. Each gummy contains a pre-measured dose of CBG, providing a consistent and convenient method for incorporating this cannabinoid into daily routines.
While CBG shows potential in promoting mental focus, supporting brain health, and fostering relaxation, further research is essential to fully understand its effects and therapeutic possibilities. Consumers should consult healthcare professionals before starting any new supplements or products.
Moreover, key players in the industry introduced innovative product launches that would propel this cannabigerol (CBG) gummies market growth. For instance, in April 2024, Rare Cannabinoid Company launched special 420 deals on its THC Mood Gummies and CBD oils, celebrating the cannabis culture and offering consumers affordable access to high-quality products. This promotion is particularly notable as it aligns with the 420 holiday, recognized in the cannabis community as a day to celebrate and advocate for cannabis use.
The THC Mood Gummies feature a blend of Delta-9-THC, CBG (cannabigerol), and CBD (cannabidiol), creating a unique edible designed to enhance mood while supporting physical wellness. Each gummy aims to provide a balanced experience, combining the euphoric effects of THC with the calming properties of CBG and CBD. This formulation is intended to offer users a natural way to manage stress and discomfort while promoting overall well-being.
Also, in October 2021, Cronos Group Inc. announced the launch of its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy, marking a significant innovation in the cannabis edible market in Canada. This product is notable as it is the first cannabis gummy in Canada to incorporate both THC and cultured cannabigerol (CBG) derived from fermentation processes, rather than directly from the cannabis plant.
The Chill Bliss gummy is designed to provide a balanced experience, delivering 10 mg of THC and 5 mg of CBG per package, which contains two gummies. Available in a Pineapple Starfruit flavor, this product aims to offer consumers a sweet and enjoyable way to experience the effects of these cannabinoids.
Geographical Analysis
North America accounted for approximately 44.2% of the global cannabigerol (CBG) gummies market share
North America region is expected to hold the largest market share over the forecast period owing to the ongoing legalization of cannabis for medical and recreational purposes in numerous states across the U.S. has greatly broadened the market for CBG products. This legal environment enables consumers to access a diverse array of cannabinoid products, including CBG gummies, without the stigma that often accompanies illegal substances.
In this region, as awareness of cannabinoids increases, a growing number of consumers are recognizing the potential benefits of cannabigerol (CBG) gummies. In contrast to more well-known cannabinoids like CBD and THC, CBG is in more demand for its distinctive properties, including anti-inflammatory effects and neuroprotective advantages. This increased awareness is fueling demand for products infused with CBG.
Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, innovative product launches, and rising customization & personalization of CBG gummies, would propel this cannabigerol (CBG) gummies market growth. For instance, in November 2023, in U.S. Rare Cannabinoid Company, a prominent innovator in the hemp industry, unveiled its innovative product THC + CBG Relief Gummies. This revolutionary edible combines the power of Delta-9-THC, CBG, and CBD, offering consumers a natural solution to support their physical well-being. Each gummy contains a potent blend of 2.5mg Delta-9-THC, 30mg CBG, and 10mg CBD in a delightful green apple flavor, with 30 gummies per bottle. This convenient and enjoyable formulation aims to provide the potential benefits of these cannabinoids for physical wellness.
Similarly, in December 2022, KANHA, a renowned cannabis brand, launched its CBG "Harmony" gummies, which are positioned as a high-end product within the cannabinoid market. Each package contains a total of 300 mg of lab-tested cannabinoids, featuring twice the CBG content compared to competing offerings. This elevated concentration of CBG is intended to provide enhanced therapeutic benefits for consumers interested in this lesser-known cannabinoid.
The Harmony gummies are specifically formulated to promote both mental and physical wellness, utilizing cannabis-derived terpenes that contribute to a more comprehensive effect. Made with real fruit flavors and all-natural ingredients, these gummies reflect KANHA's dedication to quality and consumer safety. Additionally, the incorporation of NANO technology in the formulation improves absorption, allowing effects to be felt as soon as 15 minutes after consumption.
Market Segmentation
By Category
• Cannabidiol (CBD) Edible
• Cannabigerol (CBG)
• Cannabinol (CBN)
By Flavor
• Raspberry Juice
• Strawberry Juice
• Cherry Juice
• Strawberry Puree
• Raspberry Powder
• Others
By Form
• Hard Candy
• Soft Candy
By Application
• Anti-Inflammatory
• Neuroprotection
• Anxiety and Stress Management
• Sleep Aid
• Mood Regulation
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o The rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the cannabigerol (CBG) gummies market include Curaleaf Holding Inc., The Cronos Group, Charlotte's Web, Inc., Rare Cannabinoid Company., Lazarus Naturals Inc., Hemptown Naturals, Green Roads LLC, Medterra, ENDOCA, and Extract Labs among others.
Key Developments
 In August 2024, nuEra, a prominent cannabis dispensary chain in Illinois, launched its innovative Alchemy Ratio product line, which includes both gummies and vape cartridges. This new series is crafted to provide consumers with a more balanced and therapeutic cannabis experience, delivering targeted relief through a carefully calibrated blend of cannabinoids.
Why Purchase the Report?
• To visualize the global cannabigerol (CBG) gummies market segmentation based on category, flavor, form, application, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the cannabigerol (CBG) gummies market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.
The global cannabigerol (CBG) gummies market report would provide approximately 70 tables, 67 figures, and 184 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Category
3.2. Snippet by Flavor
3.3. Snippet by Form
3.4. Snippet by Application
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Legalization of Cannabis and Product Innovations
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Production Costs
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Category
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
6.1.2. Market Attractiveness Index, By Category
6.2. Cannabidiol (CBD) Edible*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Cannabigerol (CBG)
6.4. Cannabinol (CBN)
7. By Flavor
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
7.1.2. Market Attractiveness Index, By Flavor
7.2. Raspberry Juice *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Strawberry Juice
7.4. Cherry Juice
7.5. Strawberry Puree
7.6. Raspberry Powder
7.7. Others
8. By Form
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Hard Candy*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Soft Candy
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Anti-Inflammatory*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neuroprotection
9.4. Anxiety and Stress Management
9.5. Sleep Aid
9.6. Mood Regulation
9.7. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Curaleaf Holding Inc. *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. The Cronos Group
12.3. Charlotte's Web, Inc.
12.4. Rare Cannabinoid Company.
12.5. Lazarus Naturals Inc.
12.6. Hemptown Naturals
12.7. Green Roads LLC
12.8. Medterra
12.9. ENDOCA
12.10. Extract Labs
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us